<b>Menarini</b> Expands Its Capabilities For Antibody Drug Conjugate (ADC) Projects Post author:Sam Post published:June 6, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Top GlaxoSmithKline Investor Cashes Out, Citing a Weak Pipeline and Lack of Strategic Options May 11, 2017 Kymera Emerges Out of Stealth Mode With $30M and a Top Team of Drug Hunters October 29, 2017 2 Biotechs With the Potential of Doubling Investors' Cash February 14, 2018
Top GlaxoSmithKline Investor Cashes Out, Citing a Weak Pipeline and Lack of Strategic Options May 11, 2017